Facebook Linkedin Mail X Youtube
  • Home
  • Latest News
  • Features
  • Structural Heart
  • Profiles
  • Videos
  • Events
  • Supplements
  • Past Issues
  • Subscribe
Search
Facebook Linkedin Mail X Youtube
Cardiovascular News Cardiovascular News
Cardiovascular News Cardiovascular News
  • Home
  • Latest News
  • Features
  • Structural Heart
  • Profiles
  • Videos
  • Events
  • Supplements
  • Past Issues
  • Subscribe

Tag: Claret Medical

Boston Scientific to buy cerebral protection system company

20th July 2018
Boston Scientific has sig...

ADVERTORIAL: Sentinel Cerebral Protection System provides reassurance to both physicians and patients

31st May 2018
Compared with first-g...

ADVERTORIAL: “All patients” should receive cerebral protection when undergoing TAVI procedures

16th March 2018
Data indicate that patien...

Fifty US centres are now using Claret Medical’s Sentinel cerebral protection system

15th February 2018
Since it received FDA...

Claret Medical closes on series C financing of US$14.5m

23rd October 2017
Claret Medical has an...

All-comers data indicate stroke-free survival is improved with Sentinel embolic protection device

15th September 2017
Jochen Wöhrle (Depart...

US centres of TAVI excellence start to use newly approved Sentinel device

19th June 2017
Claret Medical has an...

Sentinel becomes first cerebral protection device to receive FDA approval

5th June 2017
Claret Medical has re...

TCT 2016: SENTINEL trial fails to meet overall primary efficacy endpoint but does in adjusted model

1st November 2016
The SENTINEL trial, w...

Claret Medical submits application for FDA approval of its cerebral protection device

20th September 2016
Claret Medical has an...
Cardiovascular News

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com


BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy
Facebook Linkedin Mail X Youtube